analyse_media
Reading File
Here is a detailed analysis of Mr. Armaan's Liver Function Test (LFT) report from Dhawan Diagnostic Laboratory, dated 22-07-2026.

Patient Details

  • Name: Mr. Armaan | Age: 1 Year | Male
  • Sample ID: 124249

LFT Results Summary

TestResultReference RangeStatus
Serum Bilirubin (Total)3.3 mg/dL0.2 - 1.2🔴 HIGH
Serum Bilirubin (Direct)0.8 mg/dL0.0 - 0.30🔴 HIGH
Serum Bilirubin (Indirect)2.5 mg/dL0.0 - 0.8🔴 HIGH
AST/SGOT2340 U/L0 - 46🔴 CRITICALLY HIGH
ALT/SGPT1690 U/L0 - 49🔴 CRITICALLY HIGH
Alkaline Phosphatase154 mg/dL30 - 130🔴 HIGH
Total Protein6.4 g/dL6.0 - 8.3✅ Normal
Albumin3.7 g/dL3.4 - 5✅ Normal
Globulin2.7 g/dL1.9 - 3.9✅ Normal
A/G Ratio1.371.0 - 2.0✅ Normal

What These Results Mean

🚨 This is a Medical Emergency - Please Seek Immediate Care

AST (2340 U/L) and ALT (1690 U/L) are approximately 50x above normal. Values this high in a 1-year-old child indicate severe acute liver injury ("acute hepatitis" pattern). This needs urgent evaluation by a pediatric gastroenterologist or hepatologist.

Possible Causes to Investigate

In a 1-year-old child with this pattern (massive transaminase elevation + jaundice):
  1. Viral hepatitis - Hepatitis A (most common in this age group), EBV, CMV, or Hepatitis B
  2. Metabolic/genetic liver disease - Wilson's disease, tyrosinemia, galactosemia, or other inborn errors of metabolism
  3. Drug/toxin-induced - Any recent medications, herbal remedies, or accidental ingestion
  4. Autoimmune hepatitis - Less common at this age but possible
  5. Biliary obstruction - The high direct bilirubin (0.8, elevated) suggests some cholestatic component

Bilirubin Pattern

  • Both direct and indirect bilirubin are elevated (mixed hyperbilirubinemia), causing clinical jaundice (yellow skin/eyes)
  • Direct bilirubin being elevated points to a hepatocellular or cholestatic process

Reassuring Signs

  • Albumin (3.7) and Total Protein (6.4) are still normal - this means the liver's synthetic function is still partially preserved
  • A/G ratio is normal

⚠️ Urgent Next Steps

A doctor will likely order:
  • Viral markers: HBsAg, Anti-HAV IgM, EBV/CMV serology
  • Metabolic workup: Serum ceruloplasmin (Wilson's), urine organic acids, amino acids
  • Coagulation tests (PT/INR) - critical to assess liver synthetic function
  • Liver ultrasound with Doppler
  • Repeat LFTs to monitor trend
Please take this child to a pediatric emergency room or a pediatric gastroenterologist immediately. AST/ALT values in the 1000s-2000s range require urgent hospitalization and workup.

This analysis is for informational purposes only and does not replace professional medical advice. A doctor must evaluate this child in person.

Hepamerz injection is good for it

Finding Sources
Searching PubMed

L-ornithine L-aspartate liver injury transaminase

Searching the Web

Hepamerz LOLA injection acute hepatitis high AST ALT evidence

Reading File

Hepamerz (L-Ornithine L-Aspartate / LOLA) - Is It Right Here?

Short answer: Hepamerz is NOT the right treatment for this child's condition.
Here is why:

What Hepamerz Actually Does

Hepamerz (LOLA) works by activating the urea cycle, helping the liver convert ammonia (NH3) into urea for excretion. It is specifically indicated for:
  • Hepatic encephalopathy (HE) - confusion/coma caused by high ammonia in liver cirrhosis
  • Hyperammonemia - elevated blood ammonia levels
  • Chronic liver disease / cirrhosis with ammonia buildup
Per Sleisenger & Fordtran's Gastrointestinal and Liver Disease:
"L-ornithine-L-aspartate...activates the urea cycle and enhances ammonia clearance, has been shown in a Cochrane database review to have a possible beneficial effect on mortality, HE, and serious adverse events compared with placebo."

Why It Does NOT Apply Here

Mr. Armaan's report shows no evidence of hepatic encephalopathy or hyperammonemia. His problem is:
  • Massively elevated AST (2340) / ALT (1690) = acute hepatocellular injury (liver cell destruction)
  • Elevated bilirubin = jaundice
  • Normal albumin = synthetic function still intact
Hepamerz does not lower AST, ALT, or bilirubin. It does not treat the underlying cause of acute hepatitis. Giving it here would not help and would waste precious time.

⚠️ Especially Important: This is a 1-Year-Old Child

  • Hepamerz injection is not routinely approved or dosed for infants
  • Pediatric IV dosing carries risks if used without specialist guidance

What Actually Needs to Happen

PriorityAction
1stEmergency pediatric evaluation - AST/ALT > 50x normal is a crisis
2ndCheck PT/INR to assess risk of liver failure
3rdViral panel (Hep A, B, EBV, CMV) to find the cause
4thMetabolic workup (Wilson's, metabolic liver disease)
TreatmentDirected at the underlying cause once identified
There is no proven medication that directly lowers transaminases at this level. The treatment is identifying and removing the cause (e.g., antivirals for Hep B, stopping a toxic drug, managing metabolic disease), plus supportive care.
Please take this child to a pediatric hospital immediately - do not delay for any supplement or injection.

Find recent pediatric guidelines on acute hepatitis management

Searching PubMed

pediatric acute hepatitis management guidelines

Searching PubMed

children acute liver failure management

Searching the Web

pediatric acute hepatitis guidelines 2023 2024 ESPGHAN NASPGHAN management

!

HTTP 500 for https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?tool=orrisai&email=dev%40orris.ai&api_key=***&db=pubmed&term=%28children+acute+liver+failure+management%29+AND+%28%22Practice+Guideline%22%5Bpt%5D+OR+%22Systematic+Review%22%5Bpt%5D%29+NOT+%22Retracted+Publication%22%5Bpt%5D&retmode=json&retmax=5&sort=relevance&datetype=pdat&reldate=1825

We encountered an error while processing your request. Please try again or reach out to us for help.

Now should we give me any antibiotic therapy or any fluid

!

An error occurred (ValidationException) when calling the ConverseStream operation: Expected toolResult blocks at messages.12.content for the following Ids: tooluse_Ym5xl98xox5DCnknuMCWHu

We encountered an error while processing your request. Please try again or reach out to us for help.

This is a shared conversation. Sign in to Orris to start your own chat.